Hopwood Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Sell
2,395
-10
-0.4% -$1.5K 0.22% 54
2026
Q1
$367K Sell
2,405
-20
-0.8% -$3.07K 0.25% 51
2025
Q4
$334K Hold
2,425
0.24% 61
2025
Q3
$311K Hold
2,425
0.21% 64
2025
Q2
$293K Hold
2,425
0.23% 62
2025
Q1
$270K Hold
2,425
0.21% 65
2024
Q4
$236K Buy
+2,425
New +$259K 0.18% 78

Other funds holding NVS

Hopwood Financial Services's NVS Position: Q2 2026 in Review

Hopwood Financial Services reduced its Novartis (NVS) stake by 0.42% in Q2 2026, selling an estimated $1.5K and leaving 2,395 shares worth $375K. The position accounts for 0.22% of the portfolio, ranked #54.

Hopwood Financial Services first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. 733 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Hopwood Financial Services held 2,395 shares of Novartis worth $375K as of Q2 2026.
  • Hopwood Financial Services sold 10 Novartis shares in Q2 2026, an estimated $1.5K.
  • Novartis made up 0.22% of Hopwood Financial Services's portfolio in Q2 2026, its #54 holding.
  • Hopwood Financial Services first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
  • 733 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Hopwood Financial Services's 13F filing for Q2 2026, filed 22 Jul 2026.